Patients
141 patients who were 45-70 years age (mean age 57 y, 51% women) with type 2 diabetes, blood pressure > 140 mm Hg systolic or > 90 mm Hg diastolic, and hyperlipidaemia. Exclusion criteria included diabetes duration > 10 years, body mass index (BMI) > 35 kg/m 2 , smoking, serum creatinine > 176 mol/l, albumin to creatinine ratio ≥ 200 mg/g, and history of vascular surgery. Follow up was 91%.
Intervention
Patients were allocated to the participation programme (PP) (n=71) or to standard consultation (SC) (n=70). Patients in the PP group attended a 1 hour teaching session and were given detailed written instructions, and a copy of the structured consultation letter that was sent to their family doctor. They were given responsibility for complying with medications, monitoring treatment effects, requesting treatment changes, and achieving and maintaining target blood pressure, low density lipoprotein cholesterol (LDL C), haemoglobin A 1c (HbA 1c ), and BMI ( < 25 kg/m 2 for men and < 24 kg/m 2 for women). These patients had the option to initiate a visit or telephone conversation with a consultant when they needed advice. Patients in the SC group were given annual consultation with structured letters provided to their primary care physician. Patients in both groups received medical care by their primary care physicians.
Main outcome measures
Main outcomes were change in the glomerular filtration rate (GFR) and change in the urinary albumin to creatinine ratio. Secondary outcomes were changes in systolic and diastolic blood pressure, LDL C, and HbA 1c concentrations.
Main results
Analysis was by intention to treat. At 4 years, the PP group had a higher mean estimated GFR (98 v 91 ml/min per 1.73 m 2 , p < 0.05) and a lower mean urinary albumin to creatinine ratio (44 v 69 mg/g, p < 0.05) than the SC group. Fewer patients in the PP group developed nephropathy (defined as an albumin to creatinine ratio > 300 mg/g), new incidences of retinopathy, and cardiovascular events ( 
Conclusion
In patients with type 2 diabetes mellitus, hypertension, and hyperlipidaemia, participation in disease management improved outcomes.
*See glossary.

Patient participation (PP) v standard consultation (SC) for type 2 diabetes, hypertension, and hyperlipidaemia at 4 years †
Outcomes
PP SC RRR (95% CI) NNT (CI)
Nephropathy 0% 6% 100% (8 to 100) 18 (7 to 251) New retinopathy cases 8% 24% 65% (20 to 85) 6 (4 to 26) Cardiovascular events 34% 51% 34% (3 to 56) 6 (3 to 80) †Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.
COMMENTARY
The study by Rachmani et al adds to the literature on the benefits of actively involving patients in self management. Study participants were selected from a diabetes outpatient clinic in an academic hospital. Although participants were referred from primary care, they were a high risk group with other cardiovascular risk factors. It is possible that the PP may not be similarly effective in primary care centres without academic input. Participants in the PP group were provided with individualised, detailed instructions. These participants showed clinically and statistically significant improvement in risk factor management, which led to lower blood pressure, HBA 1c , and cholesterol concentration. However, interestingly, target concentrations were still not achieved.
This study was not designed to assess such health outcomes as cardiovascular and microvascular events. Other studies, such as the United Kingdom Prospective Diabetes Study 1 and the Heart Protection Study, 2 have shown that changes in risk factor control (eg, blood glucose, blood pressure, and cholesterol concentrations) result in improved health outcomes.
A worldwide trend exists towards self management of chronic disease. The recent introduction of Medicare funding in the US for diabetes education is an acknowledgment that funding organisations recognise the value of educating patients and building their capacity for self management. This study will help those designing future education programmes for managing diabetes and other chronic diseases.
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